D2 dissection improves disease-specific survival in advanced gastric cancer patients: 15-year follow-up results of the Italian Gastric Cancer Study Group D1 versus D2 randomised controlled trial.
Autori:
Degiuli M, Reddavid R, Tomatis M, Ponti A, Morino M, Sasako M; of the Italian Gastric Cancer Study Group (IGCSG).
Rivista:
Eur J Cancer 2021; 150: 10-22. doi: 10.1016/j.ejca.2021.03.031. Online ahead of print. PMID: 33887514 (IF 9.162)